Close Menu

NEW YORK (GenomeWeb) – Researchers have uncovered somatic recombination events in the APP gene in both people with and without Alzheimer's disease, some of which might give rise to variants that contribute to the disease.

The process appears to rely on reverse transcriptase, suggesting HIV antiretroviral drugs that block this enzyme as a potential new treatment for Alzheimer's.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.